Home > Research > Publications & Outputs > The impact of DNA repair in radiotherapy.
View graph of relations

The impact of DNA repair in radiotherapy.

Research output: Contribution to Journal/MagazineJournal article

Published

Standard

The impact of DNA repair in radiotherapy. / McMillan, T. J.
In: European Journal of Cancer, Vol. 31, No. Supple, 1995, p. S68-S69.

Research output: Contribution to Journal/MagazineJournal article

Harvard

McMillan, TJ 1995, 'The impact of DNA repair in radiotherapy.', European Journal of Cancer, vol. 31, no. Supple, pp. S68-S69. https://doi.org/10.1016/0959-8049(95)95573-O

APA

McMillan, T. J. (1995). The impact of DNA repair in radiotherapy. European Journal of Cancer, 31(Supple), S68-S69. https://doi.org/10.1016/0959-8049(95)95573-O

Vancouver

McMillan TJ. The impact of DNA repair in radiotherapy. European Journal of Cancer. 1995;31(Supple):S68-S69. doi: 10.1016/0959-8049(95)95573-O

Author

McMillan, T. J. / The impact of DNA repair in radiotherapy. In: European Journal of Cancer. 1995 ; Vol. 31, No. Supple. pp. S68-S69.

Bibtex

@article{dd8a32daa0c44ee5985f0aa642ef493d,
title = "The impact of DNA repair in radiotherapy.",
abstract = "DNA repair has an impact on radiotherapy at two levels. 1: The prolongation of treatment, either by fractionation or decreasing dose-rate allows a greater time for repair during the treatment period resulting in a reduced cytotoxicity in both tumour and normal tissues. 2: DNA repair is an important determinant of variation in cellular sensitivity. Thus variation in normal tissue damage and tumour response may be determined to a significant degree by DNA repair capacity. There have been significant advances recently in the understanding of the mechanisms and genetics of DNA repair in mammalian cells. This includes the identification of the xrcc5 gene as being part of a DNA dependent protein kinase and its association with V(D)J recombination. Such progress holds out promise for the prediction of radiosensitivity of normal and tumour cells and for the rational modification of the radiation response.",
author = "McMillan, {T. J.}",
year = "1995",
doi = "10.1016/0959-8049(95)95573-O",
language = "English",
volume = "31",
pages = "S68--S69",
journal = "European Journal of Cancer",
publisher = "Elsevier Limited",
number = "Supple",

}

RIS

TY - JOUR

T1 - The impact of DNA repair in radiotherapy.

AU - McMillan, T. J.

PY - 1995

Y1 - 1995

N2 - DNA repair has an impact on radiotherapy at two levels. 1: The prolongation of treatment, either by fractionation or decreasing dose-rate allows a greater time for repair during the treatment period resulting in a reduced cytotoxicity in both tumour and normal tissues. 2: DNA repair is an important determinant of variation in cellular sensitivity. Thus variation in normal tissue damage and tumour response may be determined to a significant degree by DNA repair capacity. There have been significant advances recently in the understanding of the mechanisms and genetics of DNA repair in mammalian cells. This includes the identification of the xrcc5 gene as being part of a DNA dependent protein kinase and its association with V(D)J recombination. Such progress holds out promise for the prediction of radiosensitivity of normal and tumour cells and for the rational modification of the radiation response.

AB - DNA repair has an impact on radiotherapy at two levels. 1: The prolongation of treatment, either by fractionation or decreasing dose-rate allows a greater time for repair during the treatment period resulting in a reduced cytotoxicity in both tumour and normal tissues. 2: DNA repair is an important determinant of variation in cellular sensitivity. Thus variation in normal tissue damage and tumour response may be determined to a significant degree by DNA repair capacity. There have been significant advances recently in the understanding of the mechanisms and genetics of DNA repair in mammalian cells. This includes the identification of the xrcc5 gene as being part of a DNA dependent protein kinase and its association with V(D)J recombination. Such progress holds out promise for the prediction of radiosensitivity of normal and tumour cells and for the rational modification of the radiation response.

U2 - 10.1016/0959-8049(95)95573-O

DO - 10.1016/0959-8049(95)95573-O

M3 - Journal article

VL - 31

SP - S68-S69

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - Supple

ER -